UK Regulator ‘Optimistic’ About EU Proposals For Northern Ireland Drug Supply
MHRA Fields Tricky Post-Brexit Regulatory Questions
Executive Summary
Among the many problems thrown up by Brexit is how to deal with situations where an innovative product that falls within the scope of the EU centralized procedure is filed in Great Britain but not in the EU, potentially denying access to the medicine in Northern Ireland. A recent webinar saw officials from the UK regulator explain the new rules on medicines supply between GB and NI.